We are live on ! Find out more
MBII

Marrone Bio Innovations, Inc.

Delisted

MBII was delisted on the 12th of July, 2022.

38 hedge funds and large institutions have $22.6M invested in Marrone Bio Innovations, Inc. in 2015 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% less funds holding

Funds holding: 4238 (-4)

10% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 10

21% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 19

56% less capital invested

Capital invested by funds: $51.7M → $22.6M (-$29.1M)

Holders
38
Holders Change
-4
Holders Change %
-9.52%
% of All Funds
1.02%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
15
Increased
9
Reduced
10
Closed
19
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
WRF
1
Waddell & Reed Financial
Kansas
$9.44M
Primecap Management
2
Primecap Management
California
$6.42M
SM
3
Senvest Management
New York
$3.03M +$1.04M +365,793 +31%
Vanguard Group
4
Vanguard Group
Pennsylvania
$800K +$21.7K +7,663 +2%
Millennium Management
5
Millennium Management
New York
$371K +$531K +187,250 New
Alyeska Investment Group
6
Alyeska Investment Group
Illinois
$364K +$152K +53,506 +41%
Northern Trust
7
Northern Trust
Illinois
$253K -$41.9K -14,787 -10%
Susquehanna International Group
8
Susquehanna International Group
Pennsylvania
$221K +$316K +111,596 New
BCM
9
Bridgeway Capital Management
Texas
$160K +$228K +80,600 New
Geode Capital Management
10
Geode Capital Management
Massachusetts
$151K -$34.3K -12,082 -14%
AIG
11
American International Group
New York
$141K -$108K -37,995 -35%
Goldman Sachs
12
Goldman Sachs
New York
$141K +$201K +71,005 New
CS
13
Credit Suisse
Switzerland
$128K +$184K +64,777 New
SCM
14
Seamans Capital Management
Massachusetts
$119K +$170K +60,000 New
Deutsche Bank
15
Deutsche Bank
Germany
$110K -$42.2K -14,900 -21%
PPA
16
Parametric Portfolio Associates
Washington
$97K -$176K -62,126 -56%
Morgan Stanley
17
Morgan Stanley
New York
$84K +$106K +37,293 +705%
BFA
18
BlackRock Fund Advisors
California
$79K -$965K -340,396 -90%
AGM
19
Alpine Global Management
New York
$66K +$95K +33,504 New
State Street
20
State Street
Massachusetts
$56K -$255K -89,889 -76%
COPPSERS
21
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$48K +$68.7K +24,231 New
ARTA
22
A.R.T. Advisors
New York
$45K +$64.8K +22,861 New
Renaissance Technologies
23
Renaissance Technologies
New York
$45K +$64.9K +22,887 New
PP
24
Paloma Partners
Connecticut
$42K +$60.8K +21,450 New
LP
25
LMR Partners
United Kingdom
$40K +$57.8K +20,375 New

MBII Hedge Fund Activity: Q2 2015 in Review

38 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q2 2015, worth a combined $22.6M — down 56% from $51.7M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of MBII and 15 opened new positions — a net loss of 4 holders — while 10 trimmed existing stakes and 9 added.

The largest buyer was Senvest Management, adding an estimated $1.04M. The largest seller was Massachusetts Financial Services, exiting entirely with an estimated $4.83M sold.

  • 38 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q2 2015, down from 42 in Q1 2015.
  • Funds reported $22.6M of Marrone Bio Innovations, Inc. stock for Q2 2015, down 56% quarter-over-quarter.
  • 15 funds opened new Marrone Bio Innovations, Inc. positions in Q2 2015 and 19 closed out, a net change of -4 holders.
  • The largest Marrone Bio Innovations, Inc. buyer in Q2 2015 was Senvest Management, an estimated $1.04M added.
  • The largest Marrone Bio Innovations, Inc. seller in Q2 2015 was Massachusetts Financial Services, an estimated $4.83M sold.

Based on aggregated 13F filings for Q2 2015.